Loading...
OTCM
ALID
Market cap0kUSD
May 27, Last price  
0.00USD
Name

Allied Corp

Chart & Performance

D1W1MN
OTCM:ALID chart
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
2.24%
Rev. gr., 5y
%
Revenues
72k
-56.46%
09,0000000012,518165,59672,096
Net income
-11m
L-36.35%
0-7,529-2,063-20,251-19,253-23,108-6,762,537-12,159,187-16,773,209-10,675,671
CFO
-2m
L-54.33%
00-4,498-14,099-21,053-12,636-3,160,802-3,956,255-4,284,266-1,956,779

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Allied Corp. (ALID) specializes in the research, development, and production of cannabinoid health solutions, primarily operating in the United States. The company markets a diverse portfolio of natural health products derived from hemp under various brands. Its "Tactical Relief" line features items such as Liberty, a CBD tincture; Tactical Hydration, a CBD-infused electrolyte beverage; FIZZ Tablets designed for water bottles; Battle Balm, a CBD roll-on formulated for activity-related aches and pains; and Quick Hit, a CBD gummy. Similarly, the "Equilibrium Bio" brand encompasses Hydrosport CBD Drink, an electrolyte beverage fortified with sodium citrate; Hydrosport Tincture, a CBD tincture enhanced with specific terpene profiles; FIZZ Tablets for customizable drinks; Sport Rub, a CBD topical for post-activity muscle relief; and Quick Hit, a CBD gummy enriched with vitamin B12. Additionally, Allied Corp. distributes a specialized skincare line under its "MaXXa" brand. This collection features Skin Structure, a facial formula for enhancing skin radiance and youthfulness; Eye Recover, designed to protect delicate eye skin from free radicals and sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer, stimulating cell regeneration and minimizing age spots; Vitamin Absolute, a hydrating facial oil; and Absolute Recover, a formulation for direct delivery of bioactive compounds to address inflammation, pain, and other skin ailments. Beyond its consumer product portfolio, Allied Corp. is also engaged in pharmaceutical development, with ALID 10 and ALID 11, experimental drug candidates, currently in Phase I clinical trials for the treatment of post-traumatic stress disorder (PTSD). Established in 2013, Allied Corp. maintains its corporate headquarters in Kelowna, Canada.
IPO date
Dec 04, 2018
Employees
Domiciled in
CA
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑082022‑082021‑082020‑082019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT